Loading clinical trials...
Loading clinical trials...
A Multicenter, Prospective, Randomized, Placebo and Collagenase (Non-surgical Standard-of-care) Controlled Study, Performed to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase in Patients With Venous Leg Ulcers
Conditions
Interventions
EscharEx (EX-03)
Placebo (Gel vehicle)
Locations
2
United States
ILD Research Center
Carlsbad, California, United States
Wojskowy Instytut Medyczny
Warsaw, Poland
Start Date
April 30, 2025
Primary Completion Date
December 30, 2027
Completion Date
September 30, 2028
Last Updated
November 15, 2024
Lead Sponsor
MediWound Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions